MRSN vs SPCE · rev $40.5M vs rev $361.0K
Mersana Therapeutics Inc (MRSN) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
MRSN currently screens at market cap $145.4M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the MRSN and SPCE stock pages for the full models.
Not investment advice.